Amlodipine/benazepril

From Self-sufficiency
Jump to: navigation, search
Amlodipine/benazepril
File:Amlodipine.svg
File:Benazepril.svg
Combination of
Amlodipine Calcium channel blocker
Benazepril ACE inhibitor
Clinical data
Pregnancy
category
  • US: D (Evidence of risk)
Routes of
administration
Oral
Legal status
Legal status
Identifiers
PubChem CID 5746247
ChemSpider 4676979
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besylate) with an angiotensin converting enzyme inhibitor (benazepril).[1] This combination agent, and other analogs, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links

  • [www.pharma.us.novartis.com/products/name/lotrel.jsp Lotrel official website] Novartis
  • Lotrel Drugs.com
  • Lotrel RxList


  1. [www.pharma.us.novartis.com/product/pi/pdf/lotrel.pdf Lotrel Prescribing Information]